# TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis

> **NCT03919435** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 8 (actual)

## Conditions studied

- Granulomatosis With Polyangiitis
- Wegener Granulomatosis

## Interventions

- **DRUG:** Trimethoprim Sulfamethoxazole

## Key facts

- **NCT ID:** NCT03919435
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-27
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03919435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03919435, "TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03919435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*